Skip to content
Study at Cambridge
About the University
Research at Cambridge
Services
Connecting Cambridge Innovation
Academic Consultancy Services
Pioneering Research Innovations
Venture Building & Investment
About
Our team
Our performance
Careers
The Cambridge Ecosystem
Beyond the University
Partnerships and collaboration
FAQs
Stories & Events
News
Events
Insights
Case Studies
Videos
Contact
Search
Menu
Archive
Posts Tagged ‘glaxosmithkline’
News
Pioneering portfolio company Apollo Therapeutics closes $226.5 million round to translate fundamental medical research into medicines
06 September 2023
Insight
Apollo Therapeutics: KE Award Winners
01 March 2022
Case Studies
Apollo Therapeutics: Pioneering collaboration launches its next phase
10 February 2022
News
An update from Apollo Therapeutics
22 February 2017
Case Studies
Novel approach could revolutionise treatment of neuropathic pain
01 June 2016
Insight
Apollo: industry expertise and pharma muscle drives science to the clinic with unparalleled speed
09 February 2016
News
Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation
25 January 2016
News
Official opening of Cambridge labs at Stevenage Bioscience Catalyst
20 March 2014
News
New treatments for pain and MS being developed in open innovation programme
25 June 2013
News
New collaboration to develop treatments for liver disease
07 September 2012
News
University of Cambridge launches Open Innovation drug discovery initiative with GSK
19 June 2012
1-11 of 11
Previous page
Next page
Page
1
1
of 1